BIIB

Biogen Inc.

231.58 USD
-0.12 (-0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Biogen Inc. stock is up 0.44% since 30 days ago. The next earnings date is Jul 23, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 51.61% of the previous 30 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 Jun 19:49 19 Jul, 2024 200.00 CALL 45 130
11 Jun 18:44 19 Jul, 2024 230.00 CALL 50 310
12 Jun 13:38 05 Jul, 2024 225.00 CALL 76 0
12 Jun 15:26 05 Jul, 2024 225.00 CALL 89 0
13 Jun 13:37 20 Jun, 2025 190.00 CALL 5 9
13 Jun 15:40 19 Jul, 2024 230.00 CALL 50 375
13 Jun 18:19 17 Jan, 2025 210.00 CALL 7 198
13 Jun 19:51 19 Jul, 2024 210.00 CALL 50 764
14 Jun 14:32 21 Jun, 2024 230.00 PUT 150 398
14 Jun 19:12 20 Jun, 2025 200.00 PUT 30 266

About Biogen Inc.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis. It also offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and pemphigus vulgaris.

  • RBC Capital
    Wed Jun 5, 10:34
    buy
    confirm
  • RBC Capital
    Wed May 29, 09:58
    buy
    confirm
  • HC Wainwright & Co.
    Thu May 23, 06:09
    buy
    confirm
  • Needham
    Wed May 22, 09:36
    buy
    confirm